Loading stock data…
Processa Pharmaceuticals (PCSA)
$2.60-0.27 (-9.41%)
Market ClosedLast close Jul 24
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Processa Pharmaceuticals, Inc. in the Healthcare sector is trading at $2.60 with a market capitalization of $6M. The stock is currently near its 52-week low of $1.67, remaining 34.2% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$3.33M↑ | -$3.70M↓ | -$3.49M↑ | -$3.95M↓ | -$2.85M |
| Net Income | -$3.38M↓ | -$3.36M↑ | -$3.44M↑ | -$3.93M↓ | -$2.83M |
Peer Comparison
JNJUNHPFE
Fundamentals
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved onco...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-555.19%
Volume
Today's trading volume
129,448
Recent News
Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline
US stocks look set to open higher in Thursday's trading session as investors dissect key inflation a
Top Midday Gainers
Processa Pharmaceuticals (PCSA) said Wednesday that an update from its phase 2 study of a combinatio
Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Insider Stock Buyers At Processa Pharmaceuticals Recouped Some Losses This Week
Insiders who bought US$213.4k worth of Processa Pharmaceuticals, Inc. ( NASDAQ:PCSA ) stock in the last year recovered...